Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy.

Kararigas G, Fliegner D, Gustafsson JÅ, Regitz-Zagrosek V.

Physiol Genomics. 2011 Apr 27;43(8):438-46. doi: 10.1152/physiolgenomics.00199.2010. Epub 2011 Feb 15.

2.

Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms.

Burns KA, Li Y, Arao Y, Petrovich RM, Korach KS.

J Biol Chem. 2011 Apr 8;286(14):12640-9. doi: 10.1074/jbc.M110.187773. Epub 2011 Feb 1.

3.

Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging.

Sindler AL, Fleenor BS, Calvert JW, Marshall KD, Zigler ML, Lefer DJ, Seals DR.

Aging Cell. 2011 Jun;10(3):429-37. doi: 10.1111/j.1474-9726.2011.00679.x. Epub 2011 Mar 31.

4.

Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats.

Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L.

PLoS One. 2010 Nov 3;5(11):e15433. doi: 10.1371/journal.pone.0015433.

5.

Metabolic impact of estrogen signalling through ERalpha and ERbeta.

Foryst-Ludwig A, Kintscher U.

J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):74-81. doi: 10.1016/j.jsbmb.2010.06.012. Epub 2010 Jul 3. Review.

PMID:
20599505
6.

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW.

J Clin Invest. 2010 Jul;120(7):2319-30. doi: 10.1172/JCI38291. Epub 2010 Jun 23.

7.

An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.

Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V.

Mol Endocrinol. 2010 Jul;24(7):1349-58. doi: 10.1210/me.2009-0441. Epub 2010 May 19.

8.

Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women.

Corcoran MP, Meydani M, Lichtenstein AH, Schaefer EJ, Dillard A, Lamon-Fava S.

J Endocrinol. 2010 Aug;206(2):217-24. doi: 10.1677/JOE-10-0057. Epub 2010 May 18.

9.

Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury.

Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR.

Surgery. 2010 Aug;148(2):436-43. doi: 10.1016/j.surg.2010.03.011.

PMID:
20434187
10.

Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females.

Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E.

Circ Res. 2010 Jun 11;106(11):1681-91. doi: 10.1161/CIRCRESAHA.109.213645. Epub 2010 Apr 22.

11.

CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.

Carascossa S, Dudek P, Cenni B, Briand PA, Picard D.

Genes Dev. 2010 Apr 1;24(7):708-19. doi: 10.1101/gad.568410.

12.

Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY.

Mol Endocrinol. 2010 Apr;24(4):709-21. doi: 10.1210/me.2009-0317. Epub 2010 Mar 2.

13.

Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women.

White RE, Gerrity R, Barman SA, Han G.

Steroids. 2010 Nov;75(11):788-93. doi: 10.1016/j.steroids.2009.12.007. Epub 2010 Jan 7. Review.

14.

Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.

Kok M, Holm-Wigerup C, Hauptmann M, Michalides R, Stål O, Linn S, Landberg G.

J Natl Cancer Inst. 2009 Dec 16;101(24):1725-9. doi: 10.1093/jnci/djp412. Erratum in: J Natl Cancer Inst. 2010 Feb 3;102(3):208.

PMID:
19940281
15.

Mitochondrial mechanisms of estrogen neuroprotection.

Simpkins JW, Yi KD, Yang SH, Dykens JA.

Biochim Biophys Acta. 2010 Oct;1800(10):1113-20. doi: 10.1016/j.bbagen.2009.11.013. Epub 2009 Nov 26. Review.

16.

17beta-Estradiol induces protein S-nitrosylation in the endothelium.

Chakrabarti S, Lekontseva O, Peters A, Davidge ST.

Cardiovasc Res. 2010 Mar 1;85(4):796-805. doi: 10.1093/cvr/cvp368. Epub 2009 Nov 13.

PMID:
19914929
17.

Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice.

Jayachandran M, Preston CC, Hunter LW, Jahangir A, Owen WG, Korach KS, Miller VM.

Age (Dordr). 2010 Mar;32(1):109-21. doi: 10.1007/s11357-009-9119-y. Epub 2009 Nov 12.

18.

Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor.

van Rooij E, Fielitz J, Sutherland LB, Thijssen VL, Crijns HJ, Dimaio MJ, Shelton J, De Windt LJ, Hill JA, Olson EN.

Circ Res. 2010 Jan 8;106(1):155-65. doi: 10.1161/CIRCRESAHA.109.207084. Epub 2009 Nov 5.

19.

BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM.

Mol Endocrinol. 2010 Jan;24(1):76-90. doi: 10.1210/me.2009-0218. Epub 2009 Nov 3.

20.

A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.

Bopassa JC, Eghbali M, Toro L, Stefani E.

Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H16-23. doi: 10.1152/ajpheart.00588.2009. Epub 2009 Oct 30.

Supplemental Content

Support Center